Skip to main content

Table 4 Comparison of non-coding haplotype distribution between patients and controls

From: Putative functional non-coding polymorphisms in SELP significantly modulate sP-selectin levels, arterial stiffness and type 2 diabetes mellitus susceptibility

Haplotypes

Patients

(N)

Freq.

(2 N = 234)

Controls

(N)

Freq.

(2 N = 232)

OR

95% CI

p value

CCAGGCCGC

38

0.1623

45

0.1939

1

1

 

CCAGGCCAC

31

0.1324

21

0.0905

1.74

0.86 to 3.53

0.119

CCGGGCCGC

20

0.0854

39

0.1681

0. 61

0.30 to 1.21

0.157

CCGGGCCAC

18

0.0769

19

0.0818

1.13

0.52 to 2.43

0.771

GCAGGCCGC

14

0.0598

4

0.0172

4.14

1.25 to 13.65

0.019a

GTAGACCGC

14

0.0598

6

0.0258

2.76

0.96 to 7.89

0.057

CCGGACCGC

11

0.0470

15

0.0646

0.86

0.35 to 2.11

0.756

CCGGACCAC

9

0.0384

8

0.0344

1.33

0.46 to 3.79

0.590

CCAGACCGC

9

0.0384

5

0.0215

2.13

0.65 to 6.90

0.206

CTAGGCCGC

7

0.0299

2

0.0086

4.14

0.81 to 21.14

0.087

GCAGACCGC

7

0.0299

19

0.0818

0.43

0.16 to 1.14

0.093

CCGAGCCGC

6

0.0256

4

0.0172

1.77

0.46 to 6.76

0.399

GCAAACCGC

6

0.0256

8

0.0344

0.88

0.28 to 2.78

0.838

CCGAGCCAC

4

0.0170

2

0.0086

2.36

0.41 to 13.64

0.334

CCAAACCGC

3

0.0128

2

0.0086

1.77

0.28 to 11.19

0.540

GCGGACCGC

3

0.0128

3

0.0129

1.18

0.22 to 6.21

0.841

CCAAGCCGC

2

0.0085

4

0.0172

0.59

0.10 to 3.41

0.557

GCAGGTCGC

1

0.0042

3

0.0129

0.39

0.03 to 3.95

0.429

  1. OR denotes for odds ratio, CI denotes for confidence interval; arepresents statistical significance at 0.05 level, Freq. denotes for frequency, N denotes for number